A phase II study of gemcitabine/nab-paclitaxel/S-1 combination neoadjuvant chemotherapy for patients with borderline resectable pancreatic cancer with arterial contact-Reference-Cited by-同舟云学术

A phase II study of gemcitabine/nab-paclitaxel/S-1 combination neoadjuvant chemotherapy for patients with borderline resectable pancreatic cancer with arterial contact

Published:2021-12 Issue: Volume:159 Page:215-223
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Kondo Naru^ORCID,Uemura Kenichiro,Sudo Takeshi,Hashimoto Yasushi,Sumiyoshi Tatsuaki,Okada Kenjiro,Seo Shingo,Otsuka Hiroyuki,Murakami Yoshiaki^ORCID,Takahashi Shinya^ORCID

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference27 articles.

1. Cancer statistics, 2020;Siegel;Ca - Cancer J Clin,2020

2. National Comprehensive Cancer Network NCCN clinical practice guidelines in oncology (NCCN Guidelines),2021

3. Clinical features and treatment outcome of borderline resectable pancreatic head/body cancer: a multi-institutional survey by the Japanese Society of Pancreatic Surgery;Kato;J Hepatobil Pancreat Sci,2013

4. National Comprehensive Cancer Network resectability status for pancreatic carcinoma predicts overall survival;Murakami;World J Surg,2015

5. Inverse probability of treatment weighting analysis of upfront surgery versus neoadjuvant chemoradiotherapy followed by surgery for pancreatic adenocarcinoma with arterial abutment;Fujii;Medicine (Baltim),2015

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic Impact of a Decrease in Serum Carbohydrate Antigen 19-9 Levels After Preoperative Therapy for 4 Months or More for Borderline Resectable Pancreatic Cancer Abutting Major Arteries;The American Surgeon™;2024-08-22

2. Impact of endoscopic ultrasound‐guided fine needle aspiration on positive peritoneal lavage cytology in patients with resectable pancreatic body and tail cancer;Journal of Hepato-Biliary-Pancreatic Sciences;2024-08-08

3. Update on the management of older patients with pancreatic adenocarcinoma: a perspective from medical oncology;Clinical and Translational Oncology;2024-02-08

4. Efficacy of first-line combination therapies versus gemcitabine monotherapy for advanced pancreatic cancer: a systematic review and network meta-analysis;American Journal of Cancer Research;2024

5. Long‐term outcomes of neoadjuvant gemcitabine, nab‐paclitaxel, and S1 (GAS) in borderline resectable pancreatic cancer with arterial contact: Results from a phase II trial;Journal of Hepato-Biliary-Pancreatic Sciences;2023-12-29